Limited synchronous hepatic resection does not compromise peri-operative outcomes or survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

about

Identification of risk factors associated with postoperative acute kidney injury after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a retrospective study.

P2860

Q38622569-FE84BFC3-F401-47C1-9777-BD461FCE19BD

P2860

Limited synchronous hepatic resection does not compromise peri-operative outcomes or survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Item

http://www.wikidata.org/entity/Q40343261

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Limited synchronous hepatic re ...... intraperitoneal chemotherapy.

@en

type

Item

label

Limited synchronous hepatic re ...... intraperitoneal chemotherapy.

@en

prefLabel

Limited synchronous hepatic re ...... intraperitoneal chemotherapy.

@en

P1476

Limited synchronous hepatic re ...... intraperitoneal chemotherapy.

@en

P2093

Akshat Saxena

http://www.w3.org/2001/XMLSchema#string

David L Morris

http://www.w3.org/2001/XMLSchema#string

Sarah J Valle

http://www.w3.org/2001/XMLSchema#string

Winston Liauw

http://www.w3.org/2001/XMLSchema#string

P2860

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases.

Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Peritonectomy procedures.

Peritoneal surface disease with synchronous hepatic involvement treated with Cytoreductive Surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).

Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination.

Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality.

Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: Systematic review of all literature and meta-analysis of observational studies.

Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study.

Peritoneal carcinomatosis with synchronous liver metastases from colorectal cancer: Who will benefit from complete cytoreductive surgery?

P304

417-424

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JSO.24543

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28181257

http://www.w3.org/2001/XMLSchema#string

Limited synchronous hepatic resection does not compromise peri-operative outcomes or survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

about

P2860

P2860

Limited synchronous hepatic resection does not compromise peri-operative outcomes or survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698